![Muscular dystrophy / Biotechnology / Duchenne muscular dystrophy / Sarepta Therapeutics / PTC Therapeutics / Exon skipping / Clinical trial / BioMarin Pharmaceutical / Draft:BMN 044 / Draft:SRP-4044 Muscular dystrophy / Biotechnology / Duchenne muscular dystrophy / Sarepta Therapeutics / PTC Therapeutics / Exon skipping / Clinical trial / BioMarin Pharmaceutical / Draft:BMN 044 / Draft:SRP-4044](/pdf-icon.png) Date: 2016-01-26 12:45:27Muscular dystrophy Biotechnology Duchenne muscular dystrophy Sarepta Therapeutics PTC Therapeutics Exon skipping Clinical trial BioMarin Pharmaceutical Draft:BMN 044 Draft:SRP-4044 | | ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and DublAdd to Reading ListSource URL: jettfoundation.orgDownload Document from Source Website File Size: 470,32 KBShare Document on Facebook
|